Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 921 1810

Fax: 604 921 1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

AliceFireSteam Aug. 19 at 2:44 PM

$BCTX Merck and Moderna have just released data on a cancer vaccine. Personalized patient-by-patient Cpi+Intismeran, slow, expensive but it works, only helps to prove the Briacell method. Bristol Myers Squibb, 11B in the vault, with no current competition against this vaccine... Buyout probably?

2 · Reply

jfun1 Aug. 19 at 2:29 PM

$BCTX Definitely eyes on the vaccines for cancer treatments. Great for humanity if they work

0 · Reply

Kirubin Aug. 19 at 2:08 PM

$BCTX okay🫡🫢

0 · Reply

letsdodiz Aug. 19 at 2:01 PM

$BCTX volume is picking up . Looks like we are getting some vibes from Moderna news. I bought some Moderna in the 20s and sold in the 50s.🥲

1 · Reply

Ares77manoe Aug. 19 at 1:57 PM

$BCTX nice

0 · Reply

AliceFireSteam Aug. 19 at 4:12 AM

$BCTX https://www.researchgate.net/scientific-contributions/William-Williams-2142334235 for those that want the underlying data (paid)

1 · Reply

USAEquityResearch Aug. 19 at 12:03 AM

$BCTX 📊 USAEquityResearch ▲ 3.53 (+4.13%) Trend: Bullish 📈 RSI (14): 52.0 — neutral territory MACD: bearish, below signal line Volume: below average 📌 Key Levels Resistance: 3.73 Support: 3.36 20-MA: 3.51 | 50-MA: 3.34 Educational content only. Not financial advice.

0 · Reply

NoFooling Aug. 18 at 6:49 PM

$BCTX watch RENMARK PRESENTATION of June 25, 2026 especially the Q&A: Best case scenario is 144th death occurs in December = Survival Readout exceeds anticipated successful June Conclusion by 6 months. https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-06-25-11-00-00/index.html

3 · Reply

smallpower17 Aug. 18 at 5:08 PM

$BCTX Rumors of great trial results leaking out??

1 · Reply

JimmyOcarri Aug. 17 at 7:46 PM

$CIIT $DCOY $BCTX $INTJ $NAAS nice

0 · Reply

BriaCell gets FDA clearance for Bria-PROS+ study in prostate cancer

Wed, 05 Aug 2026 07:30:00 -0400 - 14 days ago

BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer

2026-07-16T13:27:49.000Z - 4 weeks ago

BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site

2026-07-16T11:40:48.000Z - 4 weeks ago

BriaCell announces Odette Cancer Centre joins Bria-IMT trial

Thu, 16 Jul 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

2026-07-15T13:32:56.000Z - 5 weeks ago

BriaCell (BCTX) Partners with Fujifilm for Cell Therapy Manufacturing

2026-07-15T12:10:22.000Z - 5 weeks ago

BriaCell arranges scalable manufacturing with Fujifilm Biotechnologies

Wed, 15 Jul 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™

Tue, 07 Jul 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

2026-06-26T10:06:07.000Z - 7 weeks ago

BriaCell Partners With Uneedle To Support Scalable Microneedle Delivery Of Bria-IMT

2026-06-25T13:25:58.000Z - 7 weeks ago

BriaCell (BCTX) Partners with Uneedle for Microneedle Technology Development

2026-06-25T11:45:30.000Z - 7 weeks ago

BriaCell enters MoU with Uneedle for microneedle technology

Thu, 25 Jun 2026 07:30:00 -0400 - 7 weeks ago

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Tue, 02 Jun 2026 16:05:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Closing of Offering

Mon, 01 Jun 2026 07:30:00 -0400 - 2 months ago

BriaCell Presents Positive Clinical Data at ASCO 2026

Sun, 31 May 2026 19:59:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Pricing of Offering

2026-05-26T14:43:01.000Z - 3 months ago

BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board

2026-05-26T13:05:39.000Z - 3 months ago

BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study

Tue, 26 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-05-22T13:27:19.000Z - 3 months ago

BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026

2026-05-22T11:49:02.000Z - 3 months ago

BriaCell announces data from Bria-IMT at ASCO 2026

Fri, 22 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

Fri, 15 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

2026-05-14T15:31:53.000Z - 3 months ago

BriaCell (BCTX) Completes Manufacturing for New Prostate Cancer Treatment

Thu, 14 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

2026-05-13T16:39:28.000Z - 3 months ago

BriaCell (BCTX) Expands Clinical Trial Network for Advanced Breast Cancer Treatment

2026-05-13T14:41:55.000Z - 3 months ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

Wed, 13 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Tue, 12 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Thu, 07 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

2026-05-07T04:03:56.000Z - 3 months ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

Wed, 06 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Mon, 27 Apr 2026 07:30:00 -0400 - 4 months ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

2026-04-21T13:28:43.000Z - 4 months ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T11:54:23.000Z - 4 months ago

BriaCell presents anti-cancer activity of Bria-OTS

Tue, 21 Apr 2026 07:30:00 -0400 - 4 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

2026-04-20T13:32:04.000Z - 4 months ago

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

2026-04-20T11:41:56.000Z - 4 months ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

Mon, 20 Apr 2026 07:30:00 -0400 - 4 months ago

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Tue, 31 Mar 2026 16:05:00 -0400 - 5 months ago

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

2026-03-18T13:30:56.000Z - 5 months ago

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

2026-03-18T11:42:55.000Z - 5 months ago

BriaCell to present four posters at the 2026 AACR

Wed, 18 Mar 2026 07:30:00 -0400 - 5 months ago

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Tue, 10 Mar 2026 07:30:00 -0400 - 5 months ago

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 5 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

2026-02-18T22:51:30.000Z - 6 months ago

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

2026-02-18T22:35:25.000Z - 6 months ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

Wed, 18 Feb 2026 17:30:00 -0500 - 6 months ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

2026-02-17T12:40:59.000Z - 6 months ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

Tue, 17 Feb 2026 07:30:00 -0500 - 6 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-01-28T12:40:40.000Z - 7 months ago

BriaCell says patient images show regression, resolution of metastsized tumors

Jan 28, 2026, 7:30 AM EST - 7 months ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

2026-01-27T12:41:04.000Z - 7 months ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

Jan 27, 2026, 7:30 AM EST - 7 months ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

Jan 15, 2026, 4:05 PM EST - 7 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

Jan 13, 2026, 9:00 PM EST - 7 months ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

2026-01-13T14:41:11.000Z - 7 months ago

BriaCell Therapeutics trading resumes

2026-01-13T14:35:29.000Z - 7 months ago

BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T12:35:49.000Z - 7 months ago

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

Jan 13, 2026, 7:30 AM EST - 7 months ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Dec 18, 2025, 7:30 AM EST - 8 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

2025-12-10T12:41:29.000Z - 9 months ago

BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025

Dec 10, 2025, 7:30 AM EST - 9 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

Dec 9, 2025, 7:30 AM EST - 9 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

Dec 2, 2025, 7:30 AM EST - 9 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 9 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

Nov 20, 2025, 7:30 AM EST - 9 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 18, 2025, 7:30 AM EST - 9 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Nov 7, 2025, 7:30 AM EST - 10 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 4, 2025, 7:30 AM EST - 10 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

Oct 21, 2025, 7:50 AM EDT - 10 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:30 AM EDT - 10 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 20, 2025, 7:30 AM EDT - 10 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 11 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 3, 2025, 7:30 AM EDT - 11 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Aug 26, 2025, 7:30 AM EDT - 1 year ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 1 year ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 1 year ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 1 year ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 1 year ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 1 year ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 1 year ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

AliceFireSteam Aug. 19 at 2:44 PM

2 · Reply

jfun1 Aug. 19 at 2:29 PM

$BCTX Definitely eyes on the vaccines for cancer treatments. Great for humanity if they work

0 · Reply

Kirubin Aug. 19 at 2:08 PM

$BCTX okay🫡🫢

0 · Reply

letsdodiz Aug. 19 at 2:01 PM

$BCTX volume is picking up . Looks like we are getting some vibes from Moderna news. I bought some Moderna in the 20s and sold in the 50s.🥲

1 · Reply

Ares77manoe Aug. 19 at 1:57 PM

$BCTX nice

0 · Reply

AliceFireSteam Aug. 19 at 4:12 AM

$BCTX https://www.researchgate.net/scientific-contributions/William-Williams-2142334235 for those that want the underlying data (paid)

1 · Reply

USAEquityResearch Aug. 19 at 12:03 AM

0 · Reply

NoFooling Aug. 18 at 6:49 PM

3 · Reply

smallpower17 Aug. 18 at 5:08 PM

$BCTX Rumors of great trial results leaking out??

1 · Reply

JimmyOcarri Aug. 17 at 7:46 PM

$CIIT $DCOY $BCTX $INTJ $NAAS nice

0 · Reply

AliceFireSteam Aug. 17 at 9:25 AM

$BCTX per the sec filling of the last offering with ThinkEquity they are blocked from new offerings until September.

0 · Reply

BHWinehouse Aug. 16 at 8:28 PM

$BCTX Fun fact: Our CRO, Prevail InfoWorks, not only is our CRO but, at the time, also "saw something" that compelled them to invest in BCTX via their investment arm Prevail Partners at a 20% premium.

0 · Reply

JediGreen Aug. 16 at 10:16 AM

$BCTX If I at least recover my money from this I’m leaving my 9 to 5 putting a year supply of money on the side to live off of and dividing my account into 5 sections to trade with and as long as I’m disciplined and don’t go all in I could see myself making 2k to 4K daily and freeing myself from slavery of a 9 to 5. I guess you could say sitting and researching markets 7hrs a day is work but doing something you love and especially from from home to me is nothing like what I do right now. Last year 98 percent of my trades where green. Got a little carried away with this one. I’ve learned a very valuable lesson. Hopefully this was for a reason to truly start to learn discipline in the market at all times.

3 · Reply

JediGreen Aug. 16 at 9:30 AM

$BCTX The way I look at this is I believe around $5.50 is the true floor of this stock or my opinion is where the majority of shares are being held. I see the current price is shorts and individuals selling shares back and forth with each other to control stock price and scare people. Seems to be the art of there game. So my prediction is if phase 3 is good $5 to $6 is just the starting line of this stock.

1 · Reply

JediGreen Aug. 15 at 9:07 PM

$BCTX cleaning out a old family cabinet and found a old VHS maybe it’s a sign.

0 · Reply

AliceFireSteam Aug. 15 at 7:20 PM

$BCTX current holders per SEC filings

2 · Reply

RafaSantos Aug. 14 at 9:16 PM

$BCTX big funds buying https://www.sec.gov/edgar/search/#/q=BriaCell&dateRange=custom&startdt=2026-08-01&enddt=2026-08-14&sort=desc

2 · Reply

Rohtan Aug. 14 at 3:47 PM

$BCTX probably one more offering ???

1 · Reply

saleh1010 Aug. 14 at 2:46 PM

$BCTX I think we will break 3 again

1 · Reply

Premtracker Aug. 14 at 6:14 AM

$BCTX anyone know how long until phase 3 finishes? I’ve been bagholding this for nearly 5 years haha

2 · Reply

rp6577 Aug. 13 at 10:23 AM

$BCTX in the recent presentation they said that they ‘probably’ will announce when yhe 144 events have arisen. They then quickly caveated that they will need to give it some thought as they don’t want to be seen to be manipulating the market. The risk for them is that if there is a leak that the 144 events have arisen, then they will be forced to make the announcement. Hence I think there is a pretty good chance of them announcing the 144 events. The data would then following a few weeks later

2 · Reply

JediGreen Aug. 13 at 9:05 AM

$BCTX As we wait I got to tell you guys something. The Sony Bravia 9 TV is amazing. It’s all about the picture quality man.

0 · Reply

Market Cap	29.49M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	70,700
Avg Vol	139,788
Day's Range	N/A - N/A
Shares Out	8.70M
Stochastic %K	53%
Beta	1.14
Analysts	Strong Buy
Price Target	$40.00